Molecular Imaging: Page 292

Digirad revenues, profits dip again in Q2

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad said revenue and net income dipped slightly in the company's second quarter, while its net loss grew as the firm spent $600,000 on a stock buyback, $200,000 on legal expenses, and more on R&D as it explores ways to drive product sales growth.

July 26, 2012

FluoroPharma touts PET cardiac tracer results

By AuntMinnie.com staff writers

Imaging agent developer FluoroPharma Medical is touting results from an investigator-sponsored clinical trial in China in which patients with coronary artery disease were given the company's BFPET radiopharmaceutical to measure cardiovascular blood flow.

July 26, 2012

Covidien's Q3 sales up 3%

By AuntMinnie.com staff writers

Covidien reported top-line operational growth that was in line with expectations as the company posted a 3% gain in sales in the third quarter of fiscal 2012.

July 26, 2012

PET/MR equals PET/CT for lung cancer, with far less radiation

By Wayne Forrest

A pilot study conducted by German researchers and published in the August issue of Radiology suggests that PET/MRI provides diagnostic-quality images for assessing pulmonary masses in lung cancer cases, while cutting radiation dose by 75%.

July 26, 2012

Radiation exposure extraction tools enable dose monitoring, QA

By Cynthia E. Keen

The digitization of radiology has made the concept of efficient, cost-effective data mining possible, while the development of informatics tools is making such activity realistic. Two articles in the August issue of Radiology describe tools to extract radiation dose data.

July 25, 2012

Navidea touts Alzheimer's study

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals is promoting clinical data from a study comparing the performance characteristics of two agents used for imaging beta-amyloid protein deposits.

July 23, 2012

UPPI awarded Novation contract

By AuntMinnie.com staff writers

Nuclear pharmacy network United Pharmacy Partners (UPPI) has signed a five-year agreement with Novation to provide PET radiopharmaceuticals and support to the group purchasing organization's members, effective July 1.

July 22, 2012

Positron gets tax help for Ind. cyclotron

By AuntMinnie.com staff writers

PET developer Positron said it has accepted $30 million in economic incentives toward the cost of building a 70-MeV cyclotron in Gary, IN.

July 22, 2012

CMS takes feedback to modify PET agent review process

By Wayne Forrest

Agreeing to a request from five medical imaging organizations, the U.S. Centers for Medicare and Medicaid Services (CMS) has begun taking public comment on a proposal to streamline the process by which PET imaging agents are reviewed and approved for reimbursement.

July 22, 2012

ACC-based software boosts appropriateness of heart scans

By Eric Barnes

American College of Radiology guidelines aren't the only ones being used to develop software to rein in inappropriate utilization. A new decision-support tool based on American College of Cardiology (ACC) appropriateness criteria demonstrated its value in reducing unnecessary cardiac imaging exams in a recently completed pilot project.

July 22, 2012

PiB, FDG-PET change diagnosis for dementia patients

By Wayne Forrest

A new study by Dutch researchers adds evidence that PET imaging with carbon-11-labeled Pittsburgh Compound B (PiB) and FDG can lead to early diagnosis of Alzheimer's disease and differentiate between specific dementias, especially when previous diagnostic certainty is low.

July 19, 2012

Chinese imaging market projected to grow modestly

By AuntMinnie.com staff writers

The Chinese medical imaging market is expected to grow modestly to reach more than $2.5 billion by 2016, according to a new report from market research firm Millennium Research Group.

July 17, 2012

Previous Page

Page 292 of 611

Next Page